Neurotoxicity Research

, Volume 17, Issue 2, pp 103–113 | Cite as

Evaluation of the Importance of Astrocytes When Screening for Acute Toxicity in Neuronal Cell Systems

Article

Abstract

Reliable, high throughput, in vitro preliminary screening batteries have the potential to greatly accelerate the rate at which regulatory neurotoxicity data is generated. This study evaluated the importance of astrocytes when predicting acute toxic potential using a neuronal screening battery of pure neuronal (NT2.N) and astrocytic (NT2.A) and integrated neuronal/astrocytic (NT2.N/A) cell systems derived from the human NT2.D1 cell line, using biochemical endpoints (mitochondrial membrane potential (MMP) depolarisation and ATP and GSH depletion). Following exposure for 72 h, the known acute human neurotoxicants trimethyltin-chloride, chloroquine and 6-hydroxydopamine were frequently capable of disrupting biochemical processes in all of the cell systems at non-cytotoxic concentrations. Astrocytes provide key metabolic and protective support to neurons during toxic challenge in vivo and generally the astrocyte containing cell systems showed increased tolerance to toxicant insult compared with the NT2.N mono-culture in vitro. Whilst there was no consistent relationship between MMP, ATP and GSH log IC50 values for the NT2.N/A and NT2.A cell systems, these data did provide preliminary evidence of modulation of the acute neuronal toxic response by astrocytes. In conclusion, the suitability of NT2 neurons and astrocytes as cell systems for acute toxicity screening deserves further investigation.

Keywords

In vitro Human Neurons NT2.N NT2.A Co-culture 

Notes

Acknowledgements

The authors are grateful to the Humane Research Trust for financial support for this study.

References

  1. Almeida A, Almeida J, Bolanos JP, Moncada S (2001) Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci USA 98:15294–15299CrossRefPubMedGoogle Scholar
  2. Andrews PW (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell-Line in vitro. Dev Biol 103:285–293CrossRefPubMedGoogle Scholar
  3. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Fogh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell-line Tera-2—differentiation in vivo and in vitro. Lab Invest 50:147–162PubMedGoogle Scholar
  4. Ba F, Pang PKT, Benishin CG (2003) The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture. J Neurosci Meth 123:11–22CrossRefGoogle Scholar
  5. Bal-Price AK, Sunol C, Weiss DG, van Vliet E, Westerink RHS, Costa LG (2008) Application of in vitro neurotoxicity testing for regulatory purposes: symposium III summary and research needs. Neurotoxicology 29:520–531CrossRefPubMedGoogle Scholar
  6. Bani-Yaghoub M, Felker JM, Naus CCG (1999) Human NT2/D1 cells differentiate into functional astrocytes. NeuroReport 10:3843–3846CrossRefPubMedGoogle Scholar
  7. Blaauboer BJ (2008) The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives. Toxicol Lett 180:81–84CrossRefPubMedGoogle Scholar
  8. Bruinink A, Zimmermann G, Riesen F (1991) Neurotoxic effects of chloroquine invitro. Arch Toxicol 65:480–484CrossRefPubMedGoogle Scholar
  9. Clemedson C, Kolman A, Forsby A (2007) The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests. ATLA-Altern Lab Anim 35:33–38Google Scholar
  10. Coecke S, Eskes C, Gartlon J, Kinsner A, Price A, van Vliet E, Prieto P, Boveri M, Bremer S, Adler S (2006) The value of alternative testing for neurotoxicity in the context of regulatory needs. Environ Toxicol Pharmacol 21:153–167CrossRefGoogle Scholar
  11. Cookson MR, Mead C, Austwick SM, Pentreath VW (1995) Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell-cultures. Toxicol In Vitro 9:39–42CrossRefGoogle Scholar
  12. Costa LG (1998a) Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment. Toxicol Lett 103:417–421CrossRefGoogle Scholar
  13. Costa LG (1998b) Neurotoxicity testing: a discussion of in vitro alternatives. Environ Health Persp 106:505–510CrossRefGoogle Scholar
  14. Cristofol RM, Gasso S, Vilchez D, Pertusa M, Rodriguez-Farre E, Sanfeliu C (2004) Neurotoxic effects of trimethyltin and triethyltin on human fetal neuron and astrocyte cultures: a comparative study with rat neuronal cultures and human cell lines. Toxicol Lett 152:35–46CrossRefPubMedGoogle Scholar
  15. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 64:9–671Google Scholar
  16. Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain—metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267:4912–4916CrossRefPubMedGoogle Scholar
  17. Eyer CL, Rio C, Smith JR (2000) Trimethyltin reduces ATP levels and MTT reduction in the LRM55 rat astrocytoma cell line. Vitro Mol Toxicol 13:263–268Google Scholar
  18. Fiedorowicz A, Figiel L, Kaminska B, Zaremba M, Wilk S, Oderfeld-Nowak B (2001) Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure. Brain Res 912:116–127CrossRefPubMedGoogle Scholar
  19. Florea AM, Splettstoesser F, Dopp E, Rettenmeier AW, Busselberg D (2005) Modulation of intracellular calcium homeostasis by trimethyltin chloride in human tumour cells: neuroblastoma SY5Y and cervix adenocarcinoma HeLaS3. Toxicology 216:1–8CrossRefPubMedGoogle Scholar
  20. Forsby A, Blaauboer B (2007) Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Hum Exp Toxicol 26:333–338CrossRefPubMedGoogle Scholar
  21. Gabryel B, Adamek M, Pudelko A, Malecki A, Trzeciak HI (2002) Piracetam and vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 23:19–31CrossRefPubMedGoogle Scholar
  22. Garcia de Arriba S, Wegner F, Gruener K, Verdaguer E, Pallas M, Camins A, Wagner A, Wohlfahrt K, Allgaier C (2006) Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons. Neurochem Int 49:466–474CrossRefPubMedGoogle Scholar
  23. Gartlon J, Kinsner A, Bal-Price A, Coecke S, Clothier RH (2006) Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro 20:1569–1581CrossRefPubMedGoogle Scholar
  24. Gegg ME, Beltran B, Salas-Pino S, Bolanos JP, Clark JB, Moncada S, Heales SJ (2003) Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J Neurochem 86:228–237CrossRefPubMedGoogle Scholar
  25. Guillemain I, Alonso G, Patey G, Privat A, Chaudieu I (2000) Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. J Comp Neurol 422:380–395CrossRefPubMedGoogle Scholar
  26. Harry GJ, Tiffany-Castiglioni E (2005) Evaluation of neurotoxic potential by use of in vitro systems. Expert Opin Drug Metab Toxicol 1:701–713CrossRefPubMedGoogle Scholar
  27. Harry GJ, Billingsley M, Bruinink A, Campbell IL, Classen W, Dorman DC, Galli C, Ray D, Smith RA, Tilson HA (1998) In vitro techniques for the assessment of neurotoxicity. Environ Health Persp 106:131–158CrossRefGoogle Scholar
  28. Hartley RS, Margulis M, Fishman PS, Lee VMY, Tang CM (1999) Functional synapses are formed between human NTera2 (NT2N, hNT) neurons grown on astrocytes. J Comp Neurol 407:1–10CrossRefPubMedGoogle Scholar
  29. Heijink E, Scholten SW, Bolhuis PA, de Wolff FA (2000) Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro. Chem-Biol Interact 129:231–247CrossRefPubMedGoogle Scholar
  30. Hill EJ, Woehrling EK, Prince M, Coleman MD (2008) Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. Toxicology 249:243–250CrossRefPubMedGoogle Scholar
  31. Holden LJ, Coleman MD (2008) Further preliminary assessment of three human glioma cell lines as models of human astrocytic toxicity in vitro. Environ Toxicol Pharmacol 26:290–296CrossRefGoogle Scholar
  32. Iwasaki K, Tsuruta H (1984) Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione. Ind Health 22:177–187CrossRefPubMedGoogle Scholar
  33. Kaariainen TM, Piltonen M, Ossola B, Kekki H, Lehtonen S, Nenonen T, Lecklin A, Raasmaja A, Mannisto PT (2008) Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res 1203:149–159CrossRefPubMedGoogle Scholar
  34. Karpiak VC, Eyer CL (1999) Differential gliotoxicity of organotins. Cell Biol Toxicol 15:261–268CrossRefPubMedGoogle Scholar
  35. Larson EM, Doughman DJ, Gregerson DS, Obritsch WF (1997) A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophth Vis Sci 38:1929–1933Google Scholar
  36. Lim JH, Gibbons HM, O’Carroll SJ, Narayan PJ, Faull RLM, Dragunow M (2007) Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res 1164:1–13CrossRefPubMedGoogle Scholar
  37. Lopachin RM, Aschner M (1993) Glial neuronal interactions—relevance to neurotoxic mechanisms. Toxicol Appl Pharmacol 118:141–158CrossRefPubMedGoogle Scholar
  38. Marini AM, Nowak TS (2000) Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures. J Neurosci Res 62:814–820CrossRefPubMedGoogle Scholar
  39. Massicotte C, Knight K, Van Der Schyf CJ, Jortner BS, Ehrich M (2005) Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells. Neurotox Res 7:203–217CrossRefPubMedGoogle Scholar
  40. Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev 80:315–360PubMedGoogle Scholar
  41. Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166–174CrossRefPubMedGoogle Scholar
  42. O’Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267:5421–5426CrossRefPubMedGoogle Scholar
  43. O’Callaghan JP (1991) Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 4:197–206PubMedGoogle Scholar
  44. O’Callaghan JP, Jensen KF, Miller DB (1995) Quantitative aspects of drug and toxicant-induced astrogliosis. Neurochem Int 26:115–124CrossRefPubMedGoogle Scholar
  45. Page B, Page M, Noel C (1993) A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3:473–476Google Scholar
  46. Paquet-Durand F, Bicker G (2007) Human model neurons in studies of brain cell damage and neural repair. Curr Mol Med 7:541–554CrossRefPubMedGoogle Scholar
  47. Paquet-Durand F, Gierse A, Bicker G (2006) Diltiazem protects human NT-2 neurons against excitotoxic damage in a model of simulated ischemia. Brain Res 1124:45–54CrossRefPubMedGoogle Scholar
  48. Park JS, Choi KS, Jeong EJ, Kwon DH, Benveniste EN, Choi CH (2004) Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47:9–20CrossRefPubMedGoogle Scholar
  49. Pellerin L, Magistretti PJ (2003) How to balance the brain energy budget while spending glucose differently. J Physiol-London 546:325CrossRefPubMedGoogle Scholar
  50. Pleasure SJ, Page C, Lee VMY (1992) Pure, postmitotic, polarized human neurons derived from Ntera-2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 2:1802–1815Google Scholar
  51. Radio NM, Mundy WR (2008) Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29:361–376CrossRefPubMedGoogle Scholar
  52. Sandhu JK, Sikorska M, Walker PR (2002) Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J Neurosci Res 68:604–614CrossRefPubMedGoogle Scholar
  53. Schuliga M, Chouchane S, Snow ET (2002) Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol Sci 70:183–192CrossRefPubMedGoogle Scholar
  54. Sergent-Tanguy S, Chagneau C, Neveu I, Naveilhan P (2003) Fluorescent activated cell sorting (FACS): a rapid and reliable method to estimate the number of neurons in a mixed population. J Neurosci Meth 129:73–79CrossRefGoogle Scholar
  55. Seyfried TN, Mukherjee P (2005) Targeting energy metabolism in brain cancer: review and hypothesis. Nutr Metab 2:30–39CrossRefGoogle Scholar
  56. Slaughter MR, Bugelski PJ, O’Brien PJ (1999) Evaluation of Alamar Blue reduction for the in vitro assay of hepatocyte toxicity. Toxicol In Vitro 13:567–569CrossRefGoogle Scholar
  57. Stewart R, Christie VB, Przyborski SA (2003) Manipulation of human pluripotent embryonal carcinoma stem cells and the development of neural subtypes. Stem Cells 21:248–256CrossRefPubMedGoogle Scholar
  58. Takuma K, Baba A, Matsuda T (2004) Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72:111–127CrossRefPubMedGoogle Scholar
  59. Tieu K, Ashe PC, Zuo DM, Yu PH (2001) Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes. Neuroscience 103:125–132CrossRefPubMedGoogle Scholar
  60. Van Houten B, Woshner V, Santos JH (2006) Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 5:145–152CrossRefPubMedGoogle Scholar
  61. Veronesi B (1992) Invitro screening batteries for neurotoxicants. Neurotoxicology 13:185–195PubMedGoogle Scholar
  62. Watts LT, Rathinam ML, Schenker S, Henderson GI (2005) Astrocytes protect neurons from ethanol-induced oxidative stress and apoptotic death. J Neurosci Res 80:655–666CrossRefPubMedGoogle Scholar
  63. Woehrling EK, Hill EJ, Coleman MD (2007) Development of a neurotoxicity test-system, using human post-mitotic, astrocytic and neuronal cell lines in co-culture. Toxicol In Vitro 21:1241–1246CrossRefPubMedGoogle Scholar
  64. Wullner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Loschmann PA, Schulz JB, Weller M, Klockgether T (1999) Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 826:53–62CrossRefPubMedGoogle Scholar
  65. Xu LJ, Lee JE, Giffard RG (1999) Overexpression of bcl-2, bcl-x(L) or hsp70 in murine cortical astrocytes reduces injury of co-cultured neurons. Neurosci Lett 19:3–197Google Scholar
  66. Yu PH, Zuo DM (1997) Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes. Neuroscience 78:903–912CrossRefPubMedGoogle Scholar
  67. Zhang FL, Xu ZF, Gao J, Xu B, Deng Y (2008) In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain. Environ Toxicol Pharmacol 26:232–236CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.School of Life and Health SciencesAston UniversityBirminghamUK

Personalised recommendations